ANP32B

Acidic leucine-rich nuclear phosphoprotein 32 family member B · Q92688 · ANP32B on Sugi Atlas →

0 patent compounds predicted against ANP32B, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ANP32B by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision PHASE3COMPLETED
Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers PHASE2COMPLETED
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria PHASE2COMPLETED
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients PHASE2COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors PHASE1COMPLETED
Diagnostic and Prognostic Role of Troponin and Brain Natriuretic Peptide in Pediatric Patients With Cardiomyopathy in Correlation to Echocardiography Findings nanUNKNOWN
Idiopathic Dilated Cardiomyopathy nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
A Comparison of Rapid Immunoassay Tests for the Detection of Ruptured Membranes nanWITHDRAWN
Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors nanNOT_YET_RECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Effect of Exercise on the Human Skeletal Muscle Phosphoproteome nanCOMPLETED
Genetic Determinants of Exercise-Induced Muscle Damage (POLYGENDOMUS) nanRECRUITING
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Mapping Novel Disease Genes for Dilated Cardiomyopathy nanCOMPLETED
Prognostic Value of Protein IMP3 Expression in Cervical Cancer nanCOMPLETED
Biomarkers in SCOTland CardiomyopatHy Registry (Bio-SCOTCH) nanRECRUITING
Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer nanCOMPLETED
Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas nanACTIVE_NOT_RECRUITING
Predictive Value of Maternal Blood Protein Signatures in Preterm Birth nanCOMPLETED
A Prospective Study of Molecular Detection of Salvageable Early Recurrent Nasopharyngeal Carcinoma After Radiotherapy nanCOMPLETED
Clinical and Genetic Examinations of Dilated Cardiomyopathy nanCOMPLETED
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer nanUNKNOWN
Serum NGAL IN Patients With Multiple Myeloma nanUNKNOWN
A-protein Levels in Adult and Pediatric Brain Tumor Patients nanCOMPLETED
Molecular Genetic Epidemiology of Endocardial Cushion Defects - SCOR in Pediatric Cardiovascular Disease nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a ANP32B binder may also engage these)

ProteinNameSimilarity
Q3SZC6 1.000 Q3SZC6 →
Q8HY67 1.000 Q8HY67 →
P51122 0.998 P51122 →
Q6A1I3 0.995 Q6A1I3 →
Q7ZUP0 0.991 Q7ZUP0 →
ANP32A Acidic leucine-rich nuclear phosphoprotein 32 family member A 0.988 landscape →
Q6PAF6 0.987 Q6PAF6 →
O35381 0.978 O35381 →
P49911 0.977 P49911 →
Q9EST5 0.958 Q9EST5 →
Q6P1U7 0.957 Q6P1U7 →
Q9EST6 0.955 Q9EST6 →
Q8AVC1 0.952 Q8AVC1 →
Q5ZMN0 0.951 Q5ZMN0 →
P97822 0.940 P97822 →
Q6NUW5 0.938 Q6NUW5 →
Q5XIE0 0.934 Q5XIE0 →
Q5F4A3 0.933 Q5F4A3 →
Q9BTT0 0.930 Q9BTT0 →
Q8N108 0.909 Q8N108 →
Q5REE1 0.908 Q5REE1 →
Q5UAK0 0.906 Q5UAK0 →
Q7ZY40 0.906 Q7ZY40 →
HNRNPC Heterogeneous nuclear ribonucleoproteins C1/C2 0.904 landscape →
Q5RA82 0.901 Q5RA82 →
SET Protein SET 0.897 landscape →
NXF1 Nuclear RNA export factor 1 0.896 landscape →
Q9Z204 0.895 Q9Z204 →
Q5R752 0.894 Q5R752 →
Q8BTF8 0.894 Q8BTF8 →